Form D · Other Technology
Medical Informatics Corp.
Houston, TX · CIK 0001764954
Offering snapshot reported Jan 3, 2025 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 3, 2025 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| May 26, 2022 | Initial | $15,099,999 | No comparison | 3 | SEC filing |
| Jan 31, 2019 | Initial | $11,414,887 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-534191
Source: Form D, filed Jan 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lashonda Anderson Williams | Director |
| Jonathan Blankfein | Director |
| Emma K Fauss | Director, Executive |
| Kimberly P. Fauss | Director, Executive |
| Eric P. King | Director |
| Melli Price | Director |
| Christopher B. Raff | Executive |
| Craig G. Rusin | Director, Executive |
| Ali B. Tamaseb | Director |
| Erica Vann | Director |
| Diamantis Xylas | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1801 Binz Street Suite 450
Houston, TX, 77004
Houston, TX, 77004